BRIEF-Vexim says Anvisa approves Spinejack implants in Brazil
* HAS RECEIVED REGULATORY APPROVAL FROM ANVISA(1), BRAZIL'S NATIONAL HEALTH SURVEILLANCE AGENCY, IN ORDER TO COMMERCIALIZE SPINEJACK® IN BRAZIL.
Jan 10 Merck Kgaa :
* Signs a comprehensive materials development agreement with CLEARink Displays, Inc., aiming to bring CLEARink's innovative and patented reflective display technology to market by end of 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
SAO PAULO, May 29 Brazilian healthcare services provider Notre Dame Intermédica Sistema de Saúde SA on Monday filed for regulatory clearance to launch an initial public offering, the latest in a wave of stock listings in Latin America's largest economy after a years-long drought.